Atheroprotective Vaccination with MHC-II Restricted Peptides from ApoB-100.

Atheroprotective Vaccination with MHC-II Restricted Peptides from ApoB-100.

Item
http://www.wikidata.org/entity/Q37415733
Vaccine against arteriosclerosis: an update.Atheroprotective immunization with malondialdehyde-modified LDL is hapten specific and dependent on advanced MDA adducts: implications for development of an atheroprotective vaccineVaccination to modulate atherosclerosisSYK regulates macrophage MHC-II expression via activation of autophagy in response to oxidized LDL.Beyond vascular inflammation--recent advances in understanding atherosclerosis.Vaccination against T-cell epitopes of native ApoB100 reduces vascular inflammation and disease in a humanized mouse model of atherosclerosis.2015 Russell Ross Memorial Lecture in Vascular Biology: Protective Autoimmunity in AtherosclerosisT-Cells Specific for a Self-Peptide of ApoB-100 Exacerbate Aortic Atheroma in Murine Atherosclerosis.Progress and future opportunities in the development of vaccines against atherosclerosis.Metabolic syndrome - Removing roadblocks to therapy: Antigenic immunotherapiesAtherosclerosis and aortic aneurysm - is inflammation a common denominator?ATVB Distinguished Scientist Award: How Costimulatory and Coinhibitory Pathways Shape Atherosclerosis.Agenus’ brain cancer vaccine doubles survival rate in GBM patients.Atheroprotective vaccination with MHC-II-restricted ApoB peptides induces peritoneal IL-10-producing CD4 T cells.The cathelicidin protein CRAMP is a potential atherosclerosis self-antigen in ApoE(-/-) mice.
P2860

Atheroprotective Vaccination with MHC-II Restricted Peptides from ApoB-100.

Item
http://www.wikidata.org/entity/Q37415733
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Atheroprotective Vaccination with MHC-II Restricted Peptides from ApoB-100.
@en
Atheroprotective Vaccination with MHC-II Restricted Peptides from ApoB-100.
@nl
type
label
Atheroprotective Vaccination with MHC-II Restricted Peptides from ApoB-100.
@en
Atheroprotective Vaccination with MHC-II Restricted Peptides from ApoB-100.
@nl
prefLabel
Atheroprotective Vaccination with MHC-II Restricted Peptides from ApoB-100.
@en
Atheroprotective Vaccination with MHC-II Restricted Peptides from ApoB-100.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Atheroprotective Vaccination with MHC-II Restricted Peptides from ApoB-100.
@en
P2093
P2860
P304
P31
P356
P478
P50
P577
P5875
P698
P932